JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1996; 28:1836-1848
© 1996 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antzelevitch, C
Right arrow Articles by Yan, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antzelevitch, C
Right arrow Articles by Yan, G.

Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes

C Antzelevitch, ZQ Sun, ZQ Zhang, and GX Yan

Masonic Medical Research Laboratory Utica, New York 13501, USA. ca@mmrl.edu

OBJECTIVES: This study sought to elucidate the cellular and ionic basts for erythromycin-induced long QT syndrome. BACKGROUND: Erythromycin is known to produce long QTU intervals on the electrocardiogram (ECG) and to be associated with the development of torsade de pointes (TdP). The mechanisms responsible for the adverse effects of this widely used antibiotic are not well defined. METHODS: The present study used microelectrode and whole-cell patch-clamp techniques to assess the effects of erythromycin on epicardial, endocardial and M cells in transmural strips, arterially perfused wedges and single myocytes isolated from the canine left ventricle. RESULTS: In isolated strips, erythromycin (10 to 100 micrograms/ml) produced a much more pronounced prolongation of the action potential duration (APD) in M cells than in endocardial and epicardial cells, resulting in the development of a large dispersion of repolarization across the ventricular wall at slow stimulation rates. Erythromycin (50 to 100 micrograms/ml) induced early after depolarizations (EADs) in cells in the M (20%) but not epicardial or endocardial regions in transmural strips of ventricular free wall. Erythromycin (100 micrograms/ml) also caused APD prolongation and a transmural dispersion of repolarization, but not EADs, in intact arterially perfused wedges of canine left ventricle. These changes were attended by the development of a long QT interval on the transmural ECG. A polymorphic ventricular tachycardia closely resembling TdP was readily and reproducibly induced after erythromycin but not before. Whole-cell patch-clamp techniques, used to examine the effects of erythromycin on myocytes isolated from the M region, showed a potent effect of the drug to inhibit the rapidly activating component (IK(r)) but not the slowly activating component (IKs) of the delayed rectifier potassium current (IK). The inward rectifier current (IK1) was unaffected. CONCLUSIONS: Our data demonstrate a preferential response of M cells to the class III actions of erythromycin, due principally to the effect of the drug to inhibit IK(r) in a population of cells largely devoid of IKs. Our findings indicate that erythromycin thus produces long QT intervals as well as a prominent dispersion of repolarization across the ventricular wall, setting the stage for induction of TdP-like tachyarrhythmias displaying characteristics typical of reentry.


This article has been cited by other articles:


Home page
Circ Arrhythmia ElectrophysiolHome page
A. Burashnikov, W. Shimizu, and C. Antzelevitch
Fever Accentuates Transmural Dispersion of Repolarization and Facilitates Development of Early Afterdepolarizations and Torsade de Pointes Under Long-QT Conditions
Circ Arrhythmia Electrophysiol, August 1, 2008; 1(3): 202 - 208.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
B. D. Guth
Preclinical Cardiovascular Risk Assessment in Modern Drug Development
Toxicol. Sci., May 1, 2007; 97(1): 4 - 20.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. B. Thomsen, A. Oros, M. Schoenmakers, J. M. van Opstal, J. N. Maas, J. D.M. Beekman, and M. A. Vos
Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation
Cardiovasc Res, February 1, 2007; 73(3): 521 - 530.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Viitasalo, L. Oikarinen, H. Swan, H. Vaananen, J. Jarvenpaa, H. Hietanen, J. Karjalainen, and L. Toivonen
Effects of Beta-Blocker Therapy on Ventricular Repolarization Documented by 24-h Electrocardiography in Patients With Type 1 Long-QT Syndrome
J. Am. Coll. Cardiol., August 15, 2006; 48(4): 747 - 753.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Wisialowski, K. Crimin, J. Engtrakul, J. O'Donnell, B. Fermini, and A. A. Fossa
Differentiation of Arrhythmia Risk of the Antibacterials Moxifloxacin, Erythromycin, and Telithromycin Based on Analysis of Monophasic Action Potential Duration Alternans and Cardiac Instability
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 352 - 359.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Aiba, W. Shimizu, M. Inagaki, T. Noda, S. Miyoshi, W.-G. Ding, D. P. Zankov, F. Toyoda, H. Matsuura, M. Horie, et al.
Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil
J. Am. Coll. Cardiol., January 18, 2005; 45(2): 300 - 307.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. Van Mieghem, M. Sabbe, and D. Knockaert
The Clinical Value of the ECG in Noncardiac Conditions
Chest, April 1, 2004; 125(4): 1561 - 1576.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Fukuda, S. Miyoshi, K. Tanimoto, K. Oota, K. Fujikura, M. Iwata, A. Baba, Y. Hagiwara, T. Yoshikawa, H. Mitamura, et al.
Autoimmunity against the second extracellular loop of beta1-adrenergic receptors induces early afterdepolarization and decreases in K-channel density in rabbits
J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1090 - 1100.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
C. Antzelevitch, L. Belardinelli, L. Wu, H. Fraser, A. C. Zygmunt, A. Burashnikov, J. M. Di Diego, J. M. Fish, J. M. Cordeiro, R. J. Goodrow Jr, et al.
Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S65 - S83.
[Abstract] [PDF]


Home page
CirculationHome page
D. J. Milan, T. A. Peterson, J. N. Ruskin, R. T. Peterson, and C. A. MacRae
Drugs That Induce Repolarization Abnormalities Cause Bradycardia in Zebrafish
Circulation, March 18, 2003; 107(10): 1355 - 1358.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. N. Katchman, K. A. McGroary, M. J. Kilborn, C. A. Kornick, P. L. Manfredi, R. L. Woosley, and S. N. Ebert
Influence of Opioid Agonists on Cardiac Human Ether-a-go-go-related Gene K+ Currents
J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 688 - 694.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Milberg, L. Eckardt, H.-J. Bruns, J. Biertz, S. Ramtin, N. Reinsch, D. Fleischer, P. Kirchhof, L. Fabritz, G. Breithardt, et al.
Divergent Proarrhythmic Potential of Macrolide Antibiotics Despite Similar QT Prolongation: Fast Phase 3 Repolarization Prevents Early Afterdepolarizations and Torsade de Pointes
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 218 - 225.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Antzelevitch
Sympathetic modulation of the long QT syndrome
Eur. Heart J., August 2, 2002; 23(16): 1246 - 1252.
[PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. A. Volberg, B. J. Koci, W. Su, J. Lin, and J. Zhou
Blockade of Human Cardiac Potassium Channel Human Ether-a-go-go-Related Gene (HERG) by Macrolide Antibiotics
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 320 - 327.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
C. Antzelevitch
Heterogeneity of cellular repolarization in LQTS: the role of M cells
Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K2 - K16.
[Abstract] [PDF]


Home page
Eur Heart J SupplHome page
M.-D. Drici
Influence of gender on drug-acquired long QT syndrome
Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K41 - K47.
[Abstract] [PDF]


Home page
Eur Heart J SupplHome page
M.R. Rosen
Isolated tissue models and proarrhythmia
Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K64 - K69.
[Abstract] [PDF]


Home page
Eur Heart J SupplHome page
B. Darpo
Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes
Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K70 - K80.
[Abstract] [PDF]


Home page
Eur Heart JHome page
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al.
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450.
[PDF]


Home page
Cardiovasc ResHome page
L. M Hondeghem, K. Dujardin, and F. De Clerck
Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmia
Cardiovasc Res, May 1, 2001; 50(2): 345 - 353.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. C. Verduyn, J. M. v. Opstal, J. D. Leunissen, and M. A. Vos
Assessment of the Pro-Arrhythmic Potential of Anti-Arrhythmic Drugs: An Experimental Approach
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2001; 6(1): 89 - 97.
[PDF]


Home page
Toxicol SciHome page
K. Yamamoto, T. Tamura, R. Imai, and M. Yamamoto
Acute Canine Model for Drug-Induced Torsades de Pointes in Drug Safety Evaluation--Influences of Anesthesia and Validation with Quinidine and Astemizole
Toxicol. Sci., March 1, 2001; 60(1): 165 - 176.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
H. Ohtani, C. Taninaka, E. Hanada, H. Kotaki, H. Sato, Y. Sawada, and T. Iga
Comparative Pharmacodynamic Analysis of Q-T Interval Prolongation Induced by the Macrolides Clarithromycin, Roxithromycin, and Azithromycin in Rats
Antimicrob. Agents Chemother., October 1, 2000; 44(10): 2630 - 2637.
[Abstract] [Full Text]


Home page
Postgrad. Med. J.Home page
A Woywodt, U Grommas, W Buth, and W Rafflenbeul
QT prolongation due to roxithromycin
Postgrad. Med. J., October 1, 2000; 76(900): 651 - 653.
[Full Text]


Home page
CirculationHome page
W. Shimizu and C. Antzelevitch
Effects of a K+ Channel Opener to Reduce Transmural Dispersion of Repolarization and Prevent Torsade de Pointes in LQT1, LQT2, and LQT3 Models of the Long-QT Syndrome
Circulation, August 8, 2000; 102(6): 706 - 712.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. G.A. Volders, M. A. Vos, B. Szabo, K. R. Sipido, S.H.M. de Groot, A. P.M. Gorgels, H. J.J. Wellens, and R. Lazzara
Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts
Cardiovasc Res, June 1, 2000; 46(3): 376 - 392.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. Shimizu and C. Antzelevitch
Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome
J. Am. Coll. Cardiol., March 1, 2000; 35(3): 778 - 786.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Merot, F. Charpentier, J.-M. Poirier, G. Coutris, and J. Weissenburger
Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol
Cardiovasc Res, November 1, 1999; 44(2): 303 - 314.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Burashnikov and C. Antzelevitch
Differences in the electrophysiologic response of four canine ventricular cell types to {alpha}1-adrenergic agonists
Cardiovasc Res, September 1, 1999; 43(4): 901 - 908.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. A. Sosunov, R. Z. Gainullin, P. Danilo Jr., E. P. Anyukhovsky, M. Kirchengast, and M. R. Rosen
Electrophysiological Effects of LU111995 on Canine Hearts: In Vivo and In Vitro Studies
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 146 - 152.
[Abstract] [Full Text]


Home page
ChestHome page
A. Mishra, H. S. Friedman, and A. K. Sinha
The Effects of Erythromycin on the Electrocardiogram
Chest, April 1, 1999; 115(4): 983 - 986.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Shimizu and C. Antzelevitch
Cellular and Ionic Basis for T-Wave Alternans Under Long-QT Conditions
Circulation, March 23, 1999; 99(11): 1499 - 1507.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Khalifa, B. Drolet, P. Daleau, C. Lefez, M. Gilbert, S. Plante, G. E. O'Hara, O. Gleeton, B. A. Hamelin, and J. Turgeon
Block of Potassium Currents in Guinea Pig Ventricular Myocytes and Lengthening of Cardiac Repolarization in Man by the Histamine H1 Receptor Antagonist Diphenhydramine
J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 858 - 865.
[Abstract] [Full Text]


Home page
J CARDIOVASC PHARMACOL THERHome page
P. Geelen, B. Drolet, E. Lessard, P. Gilbert, G. E. O'Hara, and J. Turgeon
Concomitant Block of the Rapid (IKr) and Slow (IKs) Components of the Delayed Rectifier Potassium Current is Associated With Additional Drug Effects on Lengthening of Cardiac Repolarization
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(3): 143 - 150.
[Abstract] [PDF]


Home page
JAMAHome page
M.-D. Drici, B. C. Knollmann, W.-X. Wang, and R. L. Woosley
Cardiac Actions of Erythromycin: Influence of Female Sex
JAMA, November 25, 1998; 280(20): 1774 - 1776.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Shimizu and C. Antzelevitch
Cellular Basis for the ECG Features of the LQT1 Form of the Long-QT Syndrome : Effects of ß-Adrenergic Agonists and Antagonists and Sodium Channel Blockers on Transmural Dispersion of Repolarization and Torsade de Pointes
Circulation, November 24, 1998; 98(21): 2314 - 2322.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G.-X. Yan, W. Shimizu, and C. Antzelevitch
Characteristics and Distribution of M Cells in Arterially Perfused Canine Left Ventricular Wedge Preparations
Circulation, November 3, 1998; 98(18): 1921 - 1927.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G.-X. Yan and C. Antzelevitch
Cellular Basis for the Normal T Wave and the Electrocardiographic Manifestations of the Long-QT Syndrome
Circulation, November 3, 1998; 98(18): 1928 - 1936.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Eckardt, W. Haverkamp, M. Borggrefe, and G. Breithardt
Experimental models of torsade de pointes
Cardiovasc Res, July 1, 1998; 39(1): 178 - 193.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Desta, T. Kerbusch, N. Soukhova, E. Richard, J.-W. Ko, and D. A Flockhart
Identification and Characterization of Human Cytochrome P450 Isoforms Interacting with Pimozide
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 428 - 437.
[Abstract] [Full Text]


Home page
CirculationHome page
W. Shimizu, T. Kurita, K. Matsuo, K. Suyama, N. Aihara, S. Kamakura, J. A. Towbin, and K. Shimomura
Improvement of Repolarization Abnormalities by a K+ Channel Opener in the LQT1 Form of Congenital Long-QT Syndrome
Circulation, April 28, 1998; 97(16): 1581 - 1588.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. El-Sherif, M. Chinushi, E. B. Caref, and M. Restivo
Electrophysiological Mechanism of the Characteristic Electrocardiographic Morphology of Torsade de Pointes Tachyarrhythmias in the Long-QT Syndrome : Detailed Analysis of Ventricular Tridimensional Activation Patterns
Circulation, December 16, 1997; 96(12): 4392 - 4399.
[Abstract] [Full Text]


Home page
CirculationHome page
W. Shimizu and C. Antzelevitch
Sodium Channel Block With Mexiletine Is Effective in Reducing Dispersion of Repolarization and Preventing Torsade de Pointes in LQT2 and LQT3 Models of the Long-QT Syndrome
Circulation, September 16, 1997; 96(6): 2038 - 2047.
[Abstract] [Full Text]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. Sicouri, S. Moro, and M. V. Elizari
d-Sotalol Induces Marked Action Potential Prolongation and Early Afterdepolarizations in M but Not Epicardial or Endocardial Cells of the Canine Ventricle
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(1): 27 - 37.
[Abstract] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
C. Antzelevitch
The M Cell
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(1): 73 - 76.
[PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1996 by the American College of Cardiology Foundation.